Ƶ

Meeting Coverage

ASRS

American Society of Retina Specialists

Photobiomodulation for Early Dry AMD Gets Enthusiastic Reception

Significant improvement in BCVA versus historical declines, 75% decrease in new-onset cases

ASRS over a photo of Stockholmsmässan Convention Center in Stockholm, Sweden.

Latest ASRS Meeting Coverage

Could Metformin Fill the Bill for Geographic Atrophy Prevention?

Case-control study shows reduction in new-onset GA, particularly in nondiabetic patients

July 22, 2024
Sleep Apnea May Accelerate Diabetic Retinopathy

Higher rates of progression, interventions, systemic events versus retinopathy without apnea

July 21, 2024
SGLT-2 Inhibitors Top Other Diabetes Medications for Eye Safety

Significantly lower risk of diabetic macular edema, proliferative diabetic retinopathy

July 20, 2024
Pegcetacoplan Comes Out Ahead in Comparison of Drugs for Dry AMD

Propensity-matched analysis favored the C3 inhibitor over avacincaptad pegol at 12 and 24 months

July 18, 2024
Gene Therapies for Neovascular AMD Continue to Show Promise

Studies show 90% reduction in intravitreal treatment burden, durable effect on vision, anatomy

July 18, 2024
Mixed Results With Senolytic Agent for Retinal Disease

Positive outcome with UBX-1325 in diabetic macular edema but not wet AMD

August 2, 2023
Early Enthusiasm for Cancer Drug Reformulated for Ophthalmic Use

AMD treatment burden reduced by 80-90% by implant, intrachoroidal axitinib

August 2, 2023
Sticker Shock: Ophthalmic Bevacizumab Biosimilar Could Drive Up Costs

Medicare expenditures could jump 15-30%, with similar increases in patients' out-of-pocket costs

August 1, 2023
Studies Examine Links Between Diabetes and Eye Disease, Treatment, Adverse Events

Anti-VEGF therapy raises risk of systemic events; retinal effects of diabetes drugs differ

July 31, 2023
Pegcetacoplan-Related Eye Inflammation: The Search Is on for Answers

More than a half dozen reports in the last month point to no clear etiology

July 31, 2023
Durable Vision Improvement With Light Therapy for Dry Macular Degeneration

Also from ASRS: gene therapy for retinitis pigmentosa, anti-VEGF implant matches injection

July 20, 2022
Brolucizumab Prevails in Treat-and-Extend Trial of Anti-VEGF Therapy for Eye Disease

Longer treatment-free interval with similar vision outcomes versus aflibercept in neovascular AMD

July 19, 2022
Intravitreal Methotrexate Reduces Reoperation After Retinal Detachment Repair

Reoperation rate reduced by three fourths, use expanded to advanced diabetic retinopathy

July 18, 2022
Link Between Neovascular Eye Disease, CVD Tracked to Retinal Lesions

Subretinal drusenoid deposits found in 85% of patients with AMD and CVD in small study

July 16, 2022